United Therapeutics Corp. (NASDAQ:UTHR) CEO Martine Rothblatt sold 3,833 shares of United Therapeutics Corp. stock on the open market in a transaction dated Thursday, November 21st. The stock was sold at an average price of $92.49, for a total value of $354,514.17. Following the sale, the chief executive officer now directly owns 140 shares of […]
Insider Selling: Martine Rothblatt Unloads 3,833 Shares of United Therapeutics Corp. Stock (UTHR) is a post from: Zolmax
The post Insider Selling: Martine Rothblatt Unloads 3,833 Shares of United Therapeutics Corp. Stock (UTHR) appeared first on Zolmax.